Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Yokohama, KanagawaFounded 197510 employeesWebsite
A leading drugstore operator based in Kanagawa. It promotes a dominant market strategy in the Kanto region, integrating prescription pharmacies with a wide variety of daily goods.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Drugstore Retail Business | 98% | ¥488.0B | ¥0 | 0.0% |
| Supermarket Retail Operations | 1% | ¥6.6B | ¥0 | 0.0% |
| Nursing Care Services | 0% | ¥2.4B | ¥0 | 0.0% |
Close (Oct 30, 2026)
¥3,170+0.2% (1Y)
Create SD +0.2% over 1Y, 4.6pt below the industry average (55 companies, +4.8%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥497.1B | ¥24.0B | ¥17.0B | ¥255.3B | +8.8% |
| 2025FY | ¥457.1B | ¥22.6B | ¥15.7B | ¥236.6B | +8.2% |
| 2024FY | ¥422.3B | ¥20.2B | ¥13.7B | ¥216.5B | +10.9% |
| 2023FY | ¥381.0B | ¥18.9B | ¥12.9B | ¥194.9B | +8.6% |
| 2022FY | ¥350.7B | ¥18.2B | ¥12.6B | ¥176.9B | +3.6% |
| 2021FY | ¥338.5B | ¥18.6B | ¥12.4B | ¥163.8B | — |
Sources: annual securities reports, earnings releases and other public disclosures (May 2026)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
